Stem cell therapy for Alzheimer's disease

Area of Science:

• Neuroscience
• Regenerative Medicine
• Pharmacology

Background:

• Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by memory loss and cognitive decline.
• Key neuropathological hallmarks include beta-amyloid plaques, neurofibrillary tangles, and neuronal loss, particularly in the basal forebrain cholinergic system.
• Impaired neurogenesis in the adult brain may contribute to AD pathogenesis.

Purpose of the Study:

• To explore the potential of cell replacement therapy using stem cells and neural precursor cells (NPCs) for treating Alzheimer's disease.
• To investigate the capacity of stem cells to migrate, differentiate, and restore function in AD models.
• To examine the potential of enhancing endogenous neurogenesis as an alternative therapeutic strategy for AD.

Main Methods:

• Grafting of embryonic and adult stem cells into rodent brains (intact and lesioned models).
• Intravenous administration of neural precursor cells (NPCs) to assess brain migration and functional recovery.
• Analysis of stem cell survival, differentiation into neural lineages (cholinergic neurons, astrocytes, oligodendrocytes), and behavioral outcomes in AD animal models.
• Review of studies on drugs (antidepressants, lithium, acetylcholinesterase inhibitors, ginkgo biloba) that enhance neurogenesis in AD patients.

Main Results:

• Transplanted stem cells and NPCs survived, migrated to damaged areas, and differentiated into functional neural cells in AD models.
• Cell transplantation led to amelioration of learning and memory deficits.
• Stem cells stimulated endogenous neural precursors, enhanced neuroplasticity, and reduced inflammation and neuronal apoptosis.
• Pharmacological agents were shown to enhance impaired neurogenesis in AD patients, suggesting a viable therapeutic approach.

Conclusions:

• Cell replacement therapy with stem cells and NPCs demonstrates significant therapeutic potential for Alzheimer's disease by restoring neuronal function and promoting brain repair.
• Stimulating endogenous neurogenesis through pharmacological interventions represents a promising alternative or complementary strategy for treating AD.
• Further research into stem cell therapies and neurogenesis modulation is crucial for developing effective treatments for Alzheimer's disease.